{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Buchanan A"],"funding":["NCI NIH HHS"],"pagination":["526-535"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8088447"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["15(4)"],"pubmed_abstract":["<h4>Purpose</h4>The objective of this review was to assess the efficacy of non-pharmacological interventions on endometrial cancer (EC) survivors' QOL, and their use of patient-reported outcome measures (PROMs).<h4>Methods</h4>We conducted a systematic review of randomized controlled trials (RCTs) of non-pharmacological interventions that assessed the impact of intervention on EC survivors' general and domain-specific QOL (i.e., physical, psychological, and social well-being) using PROMs.<h4>Results</h4>Of the 3178 studies identified, 28 full-text articles were reviewed, and 10 were included in the review. Nine RCTs assessed at least one PROM as a primary outcome and six assessed a PROM as a secondary outcome, but few studies used validated PROMs. Significant improvements in general QOL were found in two studies, domain-specific QOL in three studies, and both general and domain-specific QOL in three studies; however, effect sizes ranged from small to large and no significant effects were found for social well-being and few were found for psychological well-being.<h4>Conclusions</h4>Few non-pharmacological interventions for EC survivors targeted QOL, even though QOL was assessed as either a primary or secondary outcome of the RCT. Despite this, findings suggest that non-pharmacological interventions for EC survivors hold promise for improving general and domain-specific QOL. Use of validated PROMs would greatly enhance outcome reporting and facilitate comparisons across studies. More interventions are also needed that address social and psychological functioning in this population.<h4>Implications for cancer survivors</h4>Our review highlights a need to (1) expand non-pharmacological RCTs for EC survivors, (2) increase the use of validated PROMs measuring QOL, and (3) address psychosocial domains of QOL when developing interventions for this population."],"journal":["Journal of cancer survivorship : research and practice"],"pubmed_title":["Patient-reported outcomes of non-pharmacological interventions for endometrial cancer survivors: a systematic review."],"pmcid":["PMC8088447"],"funding_grant_id":["P30 CA125123"],"pubmed_authors":["Roddy M","Badr H","Buchanan A"],"additional_accession":[]},"is_claimable":false,"name":"Patient-reported outcomes of non-pharmacological interventions for endometrial cancer survivors: a systematic review.","description":"<h4>Purpose</h4>The objective of this review was to assess the efficacy of non-pharmacological interventions on endometrial cancer (EC) survivors' QOL, and their use of patient-reported outcome measures (PROMs).<h4>Methods</h4>We conducted a systematic review of randomized controlled trials (RCTs) of non-pharmacological interventions that assessed the impact of intervention on EC survivors' general and domain-specific QOL (i.e., physical, psychological, and social well-being) using PROMs.<h4>Results</h4>Of the 3178 studies identified, 28 full-text articles were reviewed, and 10 were included in the review. Nine RCTs assessed at least one PROM as a primary outcome and six assessed a PROM as a secondary outcome, but few studies used validated PROMs. Significant improvements in general QOL were found in two studies, domain-specific QOL in three studies, and both general and domain-specific QOL in three studies; however, effect sizes ranged from small to large and no significant effects were found for social well-being and few were found for psychological well-being.<h4>Conclusions</h4>Few non-pharmacological interventions for EC survivors targeted QOL, even though QOL was assessed as either a primary or secondary outcome of the RCT. Despite this, findings suggest that non-pharmacological interventions for EC survivors hold promise for improving general and domain-specific QOL. Use of validated PROMs would greatly enhance outcome reporting and facilitate comparisons across studies. More interventions are also needed that address social and psychological functioning in this population.<h4>Implications for cancer survivors</h4>Our review highlights a need to (1) expand non-pharmacological RCTs for EC survivors, (2) increase the use of validated PROMs measuring QOL, and (3) address psychosocial domains of QOL when developing interventions for this population.","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Aug","modification":"2025-04-27T00:07:41.113Z","creation":"2025-04-06T17:47:08.345Z"},"accession":"S-EPMC8088447","cross_references":{"pubmed":["33140266"],"doi":["10.1007/s11764-020-00946-z"]}}